Onkologie

Pressemitteilungen

[§] European Medicines Agency accepts submission of GSK’s Marketing Authorisation Application for Niraparib in first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer

28 Februar 2020

[§] Die GSK-Vision in der Onkologie: Ein Katalysator für transformative Medizin

24 Februar 2020

[§] GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma

03 Februar 2020